FDA-cleared profile

inHEART Models

inHEART, SAS

Create, review, analyze, annotate, export, and use 3D cardiac models to support reading, reporting, and therapeutic-intervention planning.

Evidence status: each field shows source quality, applicability, and review date. Research pending, information not established in reviewed sources, and vendor documentation pending are distinct outcomes.

Clinical fit

What this tool is for

Start with the authorized purpose, then verify how it fits your service line and reading workflow.

Exact purpose
Create, review, analyze, annotate, export, and use 3D cardiac models to support reading, reporting, and therapeutic-intervention planning.
FDA source Exact FDA submission Checked 2026-09-08
Intended users
Qualified medical professionals, including physicians, cardiologists, radiologists, and technicians; final patient-management decisions remain with the users.
FDA source Exact FDA submission Checked 2026-09-08
Care setting and population
Pre-operative cardiac imaging and treatment-planning workflow; the specific facility type is not established in the FDA packet.
FDA source Exact FDA submission Checked 2026-09-08
Workflow role
AI-assisted initial 3D segmentation/modeling followed by review, editing, visualization, reporting, and treatment-planning support.
FDA source Exact FDA submission Checked 2026-09-08
Required input
DICOM-compliant pre-operative CT and MR images for the suite; inHEART Models AI specifically preprocesses CT images and is indicated for adults only.
FDA source Exact FDA submission Checked 2026-09-08
Output and human action
Automatic initial 3D segmentation/modeling from the AI module, followed by 3D cardiac models that can be displayed, reviewed, analyzed, annotated, exported, reported, and used for therapeutic planning. The packet describes 2D/3D viewers, quantitative analysis, and manual/semi-automated review and editing.
FDA source Exact FDA submission Checked 2026-09-08
Limitations
The AI module is adult and CT-only. The product is not intended for use with or primary diagnostic interpretation of mammography images. The FDA performance criteria expressly describe the AI module as an initialization step that does not replace manual expert segmentation; users review and edit outputs in the cleared suite.
FDA source Exact FDA submission Checked 2026-09-08

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K231683
FDA source Exact FDA submission Checked 2026-08-31
Modality
CT/CTA; MRI
FDA source Exact FDA submission Checked 2026-09-08
Anatomy
Cardiac structures, including the aorta, atria, ventricles, pulmonary artery trunk, and right atrium/inferior vena cava structures described in the FDA performance table
FDA source Exact FDA submission Checked 2026-09-08
Clearance type
510(k)
FDA source Exact FDA submission Checked 2026-08-31
Decision date
2024-02-29
FDA source Exact FDA submission Checked 2026-08-31
FDA status
FDA-cleared
FDA source Exact FDA submission Checked 2026-08-31

Implementation

Questions for IT, informatics, and operations

Use these fields to structure a vendor demo, security review, and implementation estimate.

Integration
Standalone and web-based software suite. The packet specifies DICOM-compliant input, a macOS imaging-processing module, a Windows/macOS web platform with supported browsers, and a standard internet connection for the web platform; exact local interface versions and deployment topology are not established.
FDA source Exact FDA submission Checked 2026-09-08
Deployment and data flow
On-cloud
Public source Exact FDA submission Checked 2026-08-13

Deployment category preserved from the prior exact-submission review; hosting region, data flow, and current commercial configuration still require vendor confirmation.

Security and privacy
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-09-08

Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.

Training and support
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-09-08

Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

Monitoring and change control
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-09-08

Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

Input or output interoperability

DICOM is explicitly referenced in the described input, output, or workflow.

exact submission · checked 2026-09-01

The model card does not establish every supported DICOM object, transfer method, or local interface.

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for inHEART Models; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-08

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version.

Evidence summary
FDA packet: 100 independent CT cases selected from 2023; two external experts established the ground truth. Performance was calculated on revised expert segmentations based on AI initialization versus ground truth/predicate outputs, rather than on unreviewed AI output alone. Average Dice was 0.94, average ASSD 1.17 mm, and average volume variation 9.18 mL/7%.
FDA source Exact FDA submission Checked 2026-09-08
Reported sensitivity
Research pending
Needs research Exact FDA submission Checked 2026-08-31

This field has not been curated yet.

Reported specificity
Research pending
Needs research Exact FDA submission Checked 2026-08-31

This field has not been curated yet.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

inHEART Models regulatory performance study summary

Stand-Alone Performance · Population described in the exact-submission ACR model card

exact submission · Tested version: Exact product version not reported; regulatory study summarized for FDA submission K231683 · n=100 · Independence not established

K231683

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Economics and lifecycle

Budget and ongoing governance

These are common procurement questions; unknown values remain visible until a source supports them.

Pricing and total cost
Vendor documentation pending
Vendor confirmation Exact FDA submission Checked 2026-09-08

No public price or quote for the exact K231683 configuration was established in this review.

Reimbursement and coding
Not established in reviewed sources
Reviewed sources checked Exact FDA submission Checked 2026-09-08

No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K231683. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
Public source Exact FDA submission Checked 2026-09-08

Buyer worksheet

Open questions to take to the vendor

Open evaluation checklist

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-08Last searched
21Fields reviewed
9Source classes checked
2Unreviewed PubMed leads
0Unreviewed trial leads
0Unreviewed FDA recall leads

Exact-submission ACR model-card fields were normalized under the current provenance rules; vendor and independent-study confirmation remain distinct. Exact FDA scope controls clinical claims. ACR provides bounded exact-submission catalog context. Candidate literature metadata remains a discovery queue until full-text identity, endpoint, population, and version review is completed. Automated exact-name discovery found 2 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads remain unpublished until a human confirms the exact product and tested version.

Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Sources

Source ledger

Sources accessed through 2026-09-08.

Alternatives

Related tools to compare

FDA-cleared K242781

cvi42 Software Application

Circle Cardiovascular Imaging Inc.

View, post-process, and qualitatively and quantitatively evaluate cardiovascular MR and CT images in DICOM format to obtain diagnostic information as part of a comprehensive...

Modality
CT/CTA; MRI
Anatomy
Cardiovascular system; heart, coronary and adjacent vessels, and cardiac valves
Decision
2024-10-15
FDA-cleared K233568

Ceevra Reveal 3+

Ceevra, Inc.

Process, review, analyze, communicate, and exchange multidimensional CT or MR images, including preliminary segmentation of normal anatomy, for preoperative surgical planning and...

Modality
CT/CTA; MRI
Anatomy
Multi-region normal anatomy represented in CT or MR images; validated examples include prostate, bladder, neurovascular bundles, kidney, artery, and vein
Decision
2023-12-05
FDA-cleared K253969

ADAS 3D

Adas3D Medical S.L.

ADAS 3D supports visualization and analysis of MR and CT images of the heart for individual patients with cardiovascular disease, including patients with myocardial scar from...

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Heart; myocardial scar and cardiac structures
Decision
2026-06-29
FDA-cleared K260667

Alturion Series Diagnostic Ultrasound System

Philips Ultrasound, LLC

Alturion Series diagnostic ultrasound systems acquire and display ultrasound images and fluid-flow information for the labeled fetal, abdominal, cardiac, cephalic, obstetric,...

Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; ophthalmic; urologic organs; and lung
Decision
2026-06-29